EVFM Presented at ROTH Capital Partners Conference
Tuesday, March 19, 2019
1:00pm EDT

Evofem Biosiciences presented at the ROTH Capital Partners 31st Annual Growth Stock Conference in Laguna Niguel, CA. Chief Medical Officer, Dr. Kelly Culwell, joined ROTH Capital analyst Yasmeen Rahimi for a fireside chat, and participated on the Disruptive Technologies: Novel Contraception and Women's Health panel. 

The webcast of the fireside chat can be accessed here: http://wsw.com/webcast/roth33/evfm/

The webcast of the Women's Health pane can be accessed here: http://www.wsw.com/webcast/roth33/panel43/?lobby=true&day=3